UnitedHealth Group Inc
NYSE:UNH
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
US |
UnitedHealth Group Inc
NYSE:UNH
|
451.2B USD | 1.2 | ||
US |
Elevance Health Inc
NYSE:ELV
|
121.8B USD | 0.7 | ||
US |
Anthem Inc
NYSE:ANTM
|
116.4B USD | 0.8 | ||
US |
Centene Corp
NYSE:CNC
|
39.9B USD | 0.3 | ||
US |
Humana Inc
NYSE:HUM
|
38.5B USD | 0.4 | ||
US |
Molina Healthcare Inc
NYSE:MOH
|
20.1B USD | 0.6 | ||
US |
Healthequity Inc
NASDAQ:HQY
|
6.7B USD | 6.7 | ||
BR |
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 3.2 | ||
BR |
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
27.9B BRL | 1 | ||
US |
Progyny Inc
NASDAQ:PGNY
|
3.1B USD | 2.8 | ||
US |
Magellan Health Inc
NASDAQ:MGLN
|
2.5B USD | 0.5 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.